Literature DB >> 25476871

Occupational Radiation Exposure During Endovascular Aortic Repair.

Anna M Sailer1, Geert Willem H Schurink, Martine E Bol, Michiel W de Haan, Willem H van Zwam, Joachim E Wildberger, Cécile R L P N Jeukens.   

Abstract

PURPOSE: The aim of the study was to evaluate the radiation exposure to operating room personnel and to assess determinants for high personal doses during endovascular aortic repair.
MATERIALS AND METHODS: Occupational radiation exposure was prospectively evaluated during 22 infra-renal aortic repair procedures (EVAR), 11 thoracic aortic repair procedures (TEVAR), and 11 fenestrated or branched aortic repair procedures (FEVAR). Real-time over-lead dosimeters attached to the left breast pocket measured personal doses for the first operators (FO) and second operators (SO), radiology technicians (RT), scrub nurses (SN), anesthesiologists (AN), and non-sterile nurses (NSN). Besides protective apron and thyroid collar, no additional radiation shielding was used. Procedural dose area product (DAP), iodinated contrast volume, fluoroscopy time, patient's body weight, and C-arm angulation were documented.
RESULTS: Average procedural FO dose was significantly higher during FEVAR (0.34 ± 0.28 mSv) compared to EVAR (0.11 ± 0.21 mSv) and TEVAR (0.06 ± 0.05 mSv; p = 0.003). Average personnel doses were 0.17 ± 0.21 mSv (FO), 0.042 ± 0.045 mSv (SO), 0.019 ± 0.042 mSv (RT), 0.017 ± 0.031 mSv (SN), 0.006 ± 0.007 mSv (AN), and 0.004 ± 0.009 mSv (NSN). SO and AN doses were strongly correlated with FO dose (p = 0.003 and p < 0.001). There was a significant correlation between FO dose and procedural DAP (R = 0.69, p < 0.001), iodinated contrast volume (R = 0.67, p < 0.001) and left-anterior C-arm projections >60° (p = 0.02), and a weak correlation with fluoroscopy time (R = 0.40, p = 0.049).
CONCLUSION: Average FO dose was a factor four higher than SO dose. Predictors for high personal doses are procedural DAP, iodinated contrast volume, and left-anterior C-arm projections greater than 60°.

Entities:  

Mesh:

Year:  2014        PMID: 25476871     DOI: 10.1007/s00270-014-1025-8

Source DB:  PubMed          Journal:  Cardiovasc Intervent Radiol        ISSN: 0174-1551            Impact factor:   2.740


  6 in total

Review 1.  Physician and Patient Radiation Exposure During Endovascular Procedures.

Authors:  Andrew M Goldsweig; J Dawn Abbott; Herbert D Aronow
Journal:  Curr Treat Options Cardiovasc Med       Date:  2017-02

2.  Radiation Awareness for Endovascular Abdominal Aortic Aneurysm Repair in the Hybrid Operating Room. An Instant Patient Risk Chart for Daily Practice.

Authors:  Quirina M de Ruiter; Crystel M Gijsberts; Constantijn E Hazenberg; Frans L Moll; Joost A van Herwaarden
Journal:  J Endovasc Ther       Date:  2017-04-10       Impact factor: 3.487

3.  Personalized Feedback on Staff Dose in Fluoroscopy-Guided Interventions: A New Era in Radiation Dose Monitoring.

Authors:  Anna M Sailer; Laura Vergoossen; Leonie Paulis; Willem H van Zwam; Marco Das; Joachim E Wildberger; Cécile R L P N Jeukens
Journal:  Cardiovasc Intervent Radiol       Date:  2017-05-12       Impact factor: 2.740

4.  Radiation-Induced DNA Damage in Operators Performing Endovascular Aortic Repair.

Authors:  Tamer El-Sayed; Ashish S Patel; Jun S Cho; James A Kelly; Francesca E Ludwinski; Prakash Saha; Oliver T Lyons; Alberto Smith; Bijan Modarai
Journal:  Circulation       Date:  2017-10-20       Impact factor: 39.918

5.  Real-Time Patient and Staff Radiation Dose Monitoring in IR Practice.

Authors:  Anna M Sailer; Leonie Paulis; Laura Vergoossen; Axel O Kovac; Geert Wijnhoven; Geert Willem H Schurink; Barend Mees; Marco Das; Joachim E Wildberger; Michiel W de Haan; Cécile R L P N Jeukens
Journal:  Cardiovasc Intervent Radiol       Date:  2016-12-09       Impact factor: 2.740

Review 6.  Occupational radiation exposure to nursing staff during cardiovascular fluoroscopic procedures: A review of the literature.

Authors:  Kelly Wilson-Stewart; Madeleine Shanahan; Davide Fontanarosa; Rob Davidson
Journal:  J Appl Clin Med Phys       Date:  2018-10-08       Impact factor: 2.102

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.